RT Journal Article
SR Electronic
T1 Can Complementary <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG PET/CT Establish the Missing Link Between Histopathology and Therapeutic Approach in Gastroenteropancreatic Neuroendocrine Tumors?
JF Journal of Nuclear Medicine
JO J Nucl Med
FD Society of Nuclear Medicine
SP 1811
OP 1817
DO 10.2967/jnumed.114.142224
VO 55
IS 11
A1 Duygu Has Simsek
A1 Serkan Kuyumcu
A1 Cuneyt Turkmen
A1 Yasemin Sanlı
A1 Faruk Aykan
A1 Seher Unal
A1 Isik Adalet
YR 2014
UL http://jnm.snmjournals.org/content/55/11/1811.abstract
AB Gastroenteropancreatic neuroendocrine tumors (GEPNETs) are indolent neoplasms presenting unpredictable and unusual biologic behavior that causes many clinical challenges. Tumor size, existence of metastasis, and histopathologic classification remain incapable in terms of treatment decision and prognosis estimation. This study aimed to compare 68Ga-DOTATATE and 18F-FDG PET/CT in GEPNETs and to investigate the relation between the complementary PET/CT results and histopathologic findings in the management of therapy, particularly in intermediate-grade patients. Methods: The relation between complementary 68Ga-DOTATATE and 18F-FDG PET/CT results of 27 GEPNET patients (mean age, 56 y; age range, 33–79 y) and histopathologic findings was evaluated according to grade and localization using standardized maximum uptake values and Ki67 indices. Grade 2 (G2) patients were further evaluated in 2 groups as G2a (3%–9%) and G2b (10%–20%) according to Ki67 indices. Results: The sensitivity of 68Ga-DOTATATE and 18F-FDG PET/CT was 95% and 37%, respectively, and the positive predictive values were 93.8% and 36.2%, respectively. The sensitivity in detecting liver metastasis, lymph nodes, bone metastasis, and primary lesion was 95%, 95%, 90%, and 93% for 68Ga-DOTATATE and 40%, 28%, 28%, and 75% for 18F-FDG, respectively. Statistically significant differences were found between grades 1–2, 2a–2b, and 1–2b with respect to 68Ga-DOTATATE PET/CT as well as between 1–2a and 1–2b with respect to 18F-FDG PET/CT. However, no statistical differences were found between 1 and 2a (P &gt; 0.05) for 68Ga-DOTATATE and 2a and 2b (P = 0.484) for 18F-FDG. The impact of the combined 18F-FDG and 68Ga-DOTATATE PET/CT on the therapeutic decision was 59%. Conclusion: Combined 68Ga-DOTATATE and 18F-FDG PET/CT is helpful in the individual therapeutic approach of GEPNETs and can overcome the shortcomings of histopathologic grading especially in intermediate-grade GEPNETs.